1. Home
  2. NREF vs CDXS Comparison

NREF vs CDXS Comparison

Compare NREF & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NREF
  • CDXS
  • Stock Information
  • Founded
  • NREF 2019
  • CDXS 2002
  • Country
  • NREF United States
  • CDXS United States
  • Employees
  • NREF N/A
  • CDXS N/A
  • Industry
  • NREF Real Estate Investment Trusts
  • CDXS Major Chemicals
  • Sector
  • NREF Real Estate
  • CDXS Industrials
  • Exchange
  • NREF Nasdaq
  • CDXS Nasdaq
  • Market Cap
  • NREF 244.3M
  • CDXS 201.3M
  • IPO Year
  • NREF 2020
  • CDXS 2010
  • Fundamental
  • Price
  • NREF $13.88
  • CDXS $2.89
  • Analyst Decision
  • NREF Hold
  • CDXS Buy
  • Analyst Count
  • NREF 3
  • CDXS 2
  • Target Price
  • NREF $14.50
  • CDXS $11.00
  • AVG Volume (30 Days)
  • NREF 72.1K
  • CDXS 873.1K
  • Earning Date
  • NREF 07-31-2025
  • CDXS 08-07-2025
  • Dividend Yield
  • NREF 14.44%
  • CDXS N/A
  • EPS Growth
  • NREF N/A
  • CDXS N/A
  • EPS
  • NREF 2.59
  • CDXS N/A
  • Revenue
  • NREF $110,996,000.00
  • CDXS $49,815,000.00
  • Revenue This Year
  • NREF $25.18
  • CDXS $12.77
  • Revenue Next Year
  • NREF $3.65
  • CDXS $22.12
  • P/E Ratio
  • NREF $5.35
  • CDXS N/A
  • Revenue Growth
  • NREF 370.78
  • CDXS N/A
  • 52 Week Low
  • NREF $12.14
  • CDXS $1.90
  • 52 Week High
  • NREF $18.09
  • CDXS $6.08
  • Technical
  • Relative Strength Index (RSI)
  • NREF 46.24
  • CDXS 61.69
  • Support Level
  • NREF $13.54
  • CDXS $2.55
  • Resistance Level
  • NREF $14.01
  • CDXS $2.91
  • Average True Range (ATR)
  • NREF 0.38
  • CDXS 0.18
  • MACD
  • NREF 0.01
  • CDXS 0.04
  • Stochastic Oscillator
  • NREF 61.71
  • CDXS 81.69

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: